Zobrazeno 1 - 10
of 101
pro vyhledávání: '"DAPA-HF"'
Autor:
Olgierd Król, Konrad Gładysz, Justyna Szydłowska, Olga Żuchnik, Piotr Kwiatkowski, Magdalena Czelej, Aleksander Kłos, Krzysztof Gieroba, Marcin Szydłowski, Paweł Zuchniak
Publikováno v:
Journal of Education, Health and Sport, Vol 13, Iss 2 (2022)
Introduction: SGLT-2 inhibitors having selectivity to sodium glucose cotransporter 2 were introduced on the market in 2012 as drugs for the pharmacotherapy of type 2 diabetes. Aim of the work: To summarize the current state of knowledge about the dru
Externí odkaz:
https://doaj.org/article/25ba551f893d4c96a5d904b3b5ecb42f
Publikováno v:
Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 823-830 (2021)
Manasvi Gupta,1 Shiavax Rao,2 Gaurav Manek,1 Gregg C Fonarow,3 Raktim K Ghosh4 1Department of Internal Medicine, University of Connecticut, Hartford, CT, USA; 2Department of Medicine, MedStar Union Memorial Hospital, Baltimore, MD, USA; 3Department o
Externí odkaz:
https://doaj.org/article/69369d87bd334ec281d0b61a674f8fe7
Autor:
Carlos Escobar, Luis Varela, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, Roberto Alcázar, Nicolás Manito, Manuel Botana
Publikováno v:
BMC Health Services Research, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background Increasing the knowledge about heart failure (HF) costs and their determinants is important to ascertain how HF management can be optimized, leading to a significant decrease of HF costs. This study evaluated the cumulative costs
Externí odkaz:
https://doaj.org/article/44057c7e20004cb2809050bb5c90f430
Autor:
Oliver Schnell, Eberhard Standl, Xavier Cos, Hiddo JL Heerspink, Baruch Itzhak, Nebojsa Lalic, Michael Nauck, Antonio Ceriello
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract The 5th Cardiovascular Outcome Trial (CVOT) Summit was held in Munich on October 24th–25th, 2019. As in previous years, this summit served as a reference meeting for in-depth discussions on the topic of recently completed and presented CVO
Externí odkaz:
https://doaj.org/article/e4be945d72bb4d2b92d3f8c00d56391f
Autor:
Edgardo Kaplinsky
Publikováno v:
Drugs in Context, Vol 9, Pp 1-7 (2020)
Heart failure (HF) continues to be a major global health problem with a notable impact in terms of morbidity and mortality and so, in consequence, with a large unmet necessity for new therapies. The inhibition of sodium–glucose cotransporter 2 (SGL
Externí odkaz:
https://doaj.org/article/abd3a7f20a994c82b9ab5db536656a24
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 5 (2020)
Patients with heart failure with reduced ejection fraction (HFrEF), despite optimal evidence-based treatment, have a high residual risk of adverse outcomes. The favorable results of studies on cardiovascular safety and the effectiveness of sodium-glu
Externí odkaz:
https://doaj.org/article/8ed31595a10c4b3cbb05aafb959d9e3a
Autor:
S. N. Tereshchenko, M. V. Shestakova, F. T. Ageev, G. R. Galstyan, A. S. Galyavich, M. G. Glezer, I. V. Zhirov, Yu. A. Karpov, Zh. D. Kobalava, S. T. Matskeplishvili
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 5 (2020)
Relationships and Activities. The Council of Experts was supported by AstraZeneca.
Externí odkaz:
https://doaj.org/article/efcda189d1b94fcebbfc56fead0270a5
Publikováno v:
Nature Reviews Nephrology. 18(5):294-306
Chronic kidney disease (CKD) and heart failure affect many people worldwide. Despite the availability of pharmacological treatments, both diseases remain associated with considerable morbidity and mortality. After observations that sodium-glucose co-
Publikováno v:
Nature Reviews Nephrology. 18(5):294-306
Chronic kidney disease (CKD) and heart failure affect many people worldwide. Despite the availability of pharmacological treatments, both diseases remain associated with considerable morbidity and mortality. After observations that sodium-glucose co-
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.